ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Ophthalmology

Top Ophthalmology Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BRIAN CRICHLOW M.D.

Ophthalmology

7,955

$624K

1332
1155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 60%

$78
Average prescription price

Avg: $73

DANIEL MESSNER MD

Ophthalmology

7,032

$508K

1159
1021 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 60%

$72
Average prescription price

Avg: $73

JEFFREY BOND MD

Ophthalmology

6,288

$434K

905
805 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 60%

$69
Average prescription price

Avg: $73

TIMOTHY BEVIS MD

Ophthalmology

6,232

$580K

1244
1103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

93%
prescriptions for brand name drugs

Avg: 60%

$93
Average prescription price

Avg: $73

KURT LARK M.D.

Ophthalmology

6,171

$359K

1233
1087 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 60%

$58
Average prescription price

Avg: $73

WILLIAM WALTON M.D.

Ophthalmology

5,892

$424K

850
763 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 60%

$72
Average prescription price

Avg: $73

CAROL ZIEL M.D.

Ophthalmology

5,802

$249K

1111
1035 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 60%

$43
Average prescription price

Avg: $73

FRANK MOYA M.D.

Ophthalmology

4,869

$358K

792
689 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 60%

$74
Average prescription price

Avg: $73

JOSEPH KRUG MD

Ophthalmology

4,758

$430K

681
627 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 60%

$90
Average prescription price

Avg: $73

WILLIAM HAYNES M.D.

Ophthalmology

4,716

$358K

742
669 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 60%

$76
Average prescription price

Avg: $73

ROBERT GROAT M.D.

Ophthalmology

4,648

$298K

837
747 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

53%
prescriptions for brand name drugs

Avg: 60%

$64
Average prescription price

Avg: $73

JAMES HOLLAND MD

Ophthalmology

4,589

$319K

1066
948 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

28%
patients receiving schedule three controlled substances

Avg: 1%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $73

ROBERT FLORES MD

Ophthalmology

4,507

$238K

790
721 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

39%
prescriptions for brand name drugs

Avg: 60%

$53
Average prescription price

Avg: $73

STEVEN STEINBERG M.D.

Ophthalmology

4,499

$295K

807
686 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 60%

$66
Average prescription price

Avg: $73

JAMES BRANCH MD

Ophthalmology

4,404

$451K

609
484 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 60%

$102
Average prescription price

Avg: $73

CHADWICK BRASINGTON

Ophthalmology

4,334

$303K

785
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $73

ROY WHITAKER MD

Ophthalmology

4,241

$436K

720
642 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

76%
prescriptions for brand name drugs

Avg: 60%

$103
Average prescription price

Avg: $73

DEMETRIAN DORNIC M.D.

Ophthalmology

4,224

$218K

945
818 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 60%

$52
Average prescription price

Avg: $73

NEIL GRIFFIN MD

Ophthalmology

4,159

$203K

1116
988 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

63%
prescriptions for brand name drugs

Avg: 60%

$49
Average prescription price

Avg: $73

JITENDRA SWARUP M.D.

Ophthalmology

4,123

$364K

1037
930 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 60%

$88
Average prescription price

Avg: $73

DAVID SMITH MD

Ophthalmology

4,098

$229K

608
551 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 60%

$56
Average prescription price

Avg: $73

MICHAEL ROTBERG M.D.

Ophthalmology

3,976

$233K

570
514 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

51%
prescriptions for brand name drugs

Avg: 60%

$59
Average prescription price

Avg: $73

KATHERINE OCHSNER MD

Ophthalmology

3,932

$392K

586
519 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 60%

$100
Average prescription price

Avg: $73

LEON HERNDON M.D.

Ophthalmology

3,864

$283K

552
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

62%
prescriptions for brand name drugs

Avg: 60%

$73
Average prescription price

Avg: $73

VICKAS KHEMSARA MD

Ophthalmology

3,851

$255K

704
637 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

55%
prescriptions for brand name drugs

Avg: 60%

$66
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank